JP2017519763A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017519763A5 JP2017519763A5 JP2016573565A JP2016573565A JP2017519763A5 JP 2017519763 A5 JP2017519763 A5 JP 2017519763A5 JP 2016573565 A JP2016573565 A JP 2016573565A JP 2016573565 A JP2016573565 A JP 2016573565A JP 2017519763 A5 JP2017519763 A5 JP 2017519763A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- pharmaceutical composition
- neprosin
- amino acid
- acid sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims 10
- 125000003275 alpha amino acid group Chemical group 0.000 claims 7
- 239000000203 mixture Substances 0.000 claims 6
- 108090000790 Enzymes Proteins 0.000 claims 4
- 102000004190 Enzymes Human genes 0.000 claims 4
- 101710008358 EMG1 Proteins 0.000 claims 3
- 101700045025 nep-2 Proteins 0.000 claims 3
- 210000002784 Stomach Anatomy 0.000 claims 2
- 235000018102 proteins Nutrition 0.000 claims 2
- 108090000623 proteins and genes Proteins 0.000 claims 2
- 102000004169 proteins and genes Human genes 0.000 claims 2
- 208000006096 Attention Deficit Disorder with Hyperactivity Diseases 0.000 claims 1
- 206010003736 Attention deficit/hyperactivity disease Diseases 0.000 claims 1
- 206010003805 Autism Diseases 0.000 claims 1
- 206010009839 Coeliac disease Diseases 0.000 claims 1
- 206010012468 Dermatitis herpetiformis Diseases 0.000 claims 1
- 208000001640 Fibromyalgia Diseases 0.000 claims 1
- 108010068370 Glutens Proteins 0.000 claims 1
- 206010020751 Hypersensitivity Diseases 0.000 claims 1
- 206010061218 Inflammation Diseases 0.000 claims 1
- 210000000936 Intestines Anatomy 0.000 claims 1
- 241000208720 Nepenthes Species 0.000 claims 1
- 102000007312 Recombinant Proteins Human genes 0.000 claims 1
- 108010033725 Recombinant Proteins Proteins 0.000 claims 1
- 206010039073 Rheumatoid arthritis Diseases 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 201000005794 allergic hypersensitivity disease Diseases 0.000 claims 1
- 239000000427 antigen Substances 0.000 claims 1
- 102000038129 antigens Human genes 0.000 claims 1
- 108091007172 antigens Proteins 0.000 claims 1
- 201000006287 attention deficit hyperactivity disease Diseases 0.000 claims 1
- 201000002055 autistic disease Diseases 0.000 claims 1
- 239000003405 delayed action preparation Substances 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 235000013305 food Nutrition 0.000 claims 1
- 238000009472 formulation Methods 0.000 claims 1
- 235000021312 gluten Nutrition 0.000 claims 1
- 230000009610 hypersensitivity Effects 0.000 claims 1
- 230000004054 inflammatory process Effects 0.000 claims 1
- 230000000968 intestinal Effects 0.000 claims 1
- 239000002365 multiple layer Substances 0.000 claims 1
- 230000001264 neutralization Effects 0.000 claims 1
- 239000000546 pharmaceutic aid Substances 0.000 claims 1
- 239000000825 pharmaceutical preparation Substances 0.000 claims 1
Claims (14)
- 患者の腸におけるペプチド性食品抗原の存在が原因の腸の炎症を減弱または予防するための、ネペンテシンＩ、ネペンテシンＩＩ、ネプロシン、それらの変異体及びそれらの混合物からなる群から選択される酵素を含む医薬組成物の使用。
- 前記患者がグルテン過敏症、セリアック病、注意欠陥多動性障害、自閉症、関節リウマチ、線維筋痛症及びヘルペス状皮膚炎からなる群から選択される疾患を罹患している、請求項１に記載の使用。
- 前記ネペンテシンＩ、ネペンテシンＩＩ、ネプロシン、それらの変異体またはそれらの混合物が組換えタンパク質である、請求項１に記載の使用。
- 前記医薬組成物の単位用量が、約１ｍｇ〜約２５ｇの間の前記酵素を含む、請求項１〜３のいずれか１項に記載の使用。
- 前記医薬組成物が約ｐＨ５〜約ｐＨ８の間である、請求項１〜３のいずれか１項に記載の使用。
- 前記変異体が、配列番号１、配列番号５、配列番号６、配列番号７、配列番号８、配列番号９、配列番号２０及び配列番号２１からなる群から選択されるアミノ酸配列に対して少なくとも８５％の配列相同性を有するアミノ酸配列を有するタンパク質である、請求項１〜３のいずれか１項に記載の使用。
- ネプロシンが、配列番号１のアミノ酸配列に対して少なくとも９０％の配列相同性を有するアミノ酸配列を含むタンパク質である、ネプロシン及び医薬的に許容可能な適切な賦形剤を含む医薬組成物。
- 前記ネプロシンの前記アミノ酸配列が、シグナル配列を有さない配列番号１のアミノ酸配列に対して少なくとも９０％の配列相同性を有するアミノ酸配列を含む、請求項７に記載の医薬組成物。
- 少なくとも１種のさらなるＮｅｐｅｎｔｈｅｓ酵素またはその変異体をさらに含む、請求項８に記載の医薬組成物。
- 前記少なくとも１種のさらなるＮｅｐｅｎｔｈｅｓ酵素またはその変異体がネペンテシンＩ、ネペンテシンＩＩ及び／またはそれらの変異体である、請求項７〜９のいずれか１項に記載の医薬組成物。
- 持続性放出製剤である、請求項７〜９のいずれか１項に記載の医薬組成物。
- 前記組成物が中性ｐＨで維持される、請求項７〜９のいずれか１項に記載の医薬組成物。
- 前記ネプロシンが多層中に存在し、その結果、前記製剤が胃の中に存在する間、前記ネプロシンが継続的に放出される、請求項７〜１２のいずれか１項に記載の組成物を含む医薬製剤。
- さらに医薬的に許容可能な緩衝液を含み、その結果、胃の中で酸に接触した際にネプロシンのｐＨがｐＨ５または６にとどまる、請求項７〜１２のいずれか１項に記載の組成物を含む医薬製剤。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021007953A JP7369893B2 (ja) | 2014-06-16 | 2021-01-21 | グルテン不耐症及びそれから生じる障害を治療するための組成物及び方法 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462012865P | 2014-06-16 | 2014-06-16 | |
| US62/012,865 | 2014-06-16 | ||
| US201562118396P | 2015-02-19 | 2015-02-19 | |
| US62/118,396 | 2015-02-19 | ||
| PCT/CA2015/000389 WO2015192211A1 (en) | 2014-06-16 | 2015-06-16 | Compositions and methods for treating gluten intolerance and disorders arising therefrom |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021007953A Division JP7369893B2 (ja) | 2014-06-16 | 2021-01-21 | グルテン不耐症及びそれから生じる障害を治療するための組成物及び方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017519763A JP2017519763A (ja) | 2017-07-20 |
| JP2017519763A5 true JP2017519763A5 (ja) | 2018-07-26 |
| JP6829077B2 JP6829077B2 (ja) | 2021-02-10 |
Family
ID=54934596
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016573565A Active JP6829077B2 (ja) | 2014-06-16 | 2015-06-16 | グルテン不耐症及びそれから生じる障害を治療するための組成物及び方法 |
| JP2021007953A Active JP7369893B2 (ja) | 2014-06-16 | 2021-01-21 | グルテン不耐症及びそれから生じる障害を治療するための組成物及び方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021007953A Active JP7369893B2 (ja) | 2014-06-16 | 2021-01-21 | グルテン不耐症及びそれから生じる障害を治療するための組成物及び方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (3) | US20160022785A1 (ja) |
| EP (2) | EP3943104A1 (ja) |
| JP (2) | JP6829077B2 (ja) |
| CN (2) | CN113827708A (ja) |
| DK (1) | DK3220946T3 (ja) |
| ES (1) | ES2883347T3 (ja) |
| SI (1) | SI3220946T1 (ja) |
| WO (1) | WO2015192211A1 (ja) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK3220946T3 (da) | 2014-06-16 | 2021-08-02 | Codexis Inc | Sammensætninger og fremgangsmåder til dæmpning og forebyggelse af tarminflammation på grund af tilstedeværelsen af peptidiske fødevareantigener i tarmen |
| US10857214B2 (en) | 2015-12-16 | 2020-12-08 | Codexis, Inc. | Compositions and methods for treating gluten intolerance and disorders arising therefrom |
| CN108504615B (zh) * | 2018-03-30 | 2020-12-29 | 江南大学 | 一种产酸性蛋白酶的重组菌及其应用 |
| WO2023220658A2 (en) * | 2022-05-10 | 2023-11-16 | Codexis, Inc. | Recombinant neprosin polypeptides and methods of expression |
| CN115336666A (zh) * | 2022-07-05 | 2022-11-15 | 熊子奕 | 猪笼草捕虫囊蛋白酶降低乳清蛋白致敏性的应用及方法 |
Family Cites Families (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK81193D0 (da) | 1993-07-06 | 1993-07-06 | Novo Nordisk As | Enzym |
| JP3767831B2 (ja) | 1995-06-14 | 2006-04-19 | 木村 健 | ヘリコバクター・ピロリ除菌用組成物 |
| JPH1149697A (ja) | 1997-08-01 | 1999-02-23 | Nisshin Flour Milling Co Ltd | ストレス抑制剤及びストレス抑制用食品 |
| FI980410A0 (fi) | 1998-02-23 | 1998-02-23 | Tapio Raivio | Termoset |
| DE19980245D2 (de) | 1998-02-23 | 2001-05-10 | Keller Helmut | Verwendung eines Preßsaftes, Verdauungssaftes oder Extraktes von fleischfressenden Pflanzen zur Hemmung von Proteinkinasen |
| JP2003533335A (ja) | 2000-05-22 | 2003-11-11 | オーバス メディカル テクノロジーズ インク． | 自己拡張形ステント |
| US7303871B2 (en) | 2002-02-14 | 2007-12-04 | The Board Of Trustees Of The Leland Stanford Junior University | Enzyme treatment of foodstuffs for Celiac Sprue |
| US7320788B2 (en) * | 2002-02-14 | 2008-01-22 | The Board Of Trustees Of The Leland Stanford Junior University | Enzyme treatment of foodstuffs for Celiac Sprue |
| US8143210B2 (en) | 2002-02-14 | 2012-03-27 | The Board Of Trustees Of The Leland Stanford Junior University | Enzyme treatment of foodstuffs for celiac sprue |
| JP4415244B2 (ja) | 2003-02-21 | 2010-02-17 | グリコ栄養食品株式会社 | 小麦蛋白質にプロテアーゼを限定的に作用させて得られる食品素材 |
| US7122035B2 (en) | 2003-11-13 | 2006-10-17 | Jerome Canady | Bipolar surgical forceps with argon plasma coagulation capability |
| CN100384442C (zh) * | 2004-01-13 | 2008-04-30 | 吴琼汉 | 一种中草药制剂及其制备方法和应用 |
| US7628985B2 (en) | 2004-04-26 | 2009-12-08 | The Board Of Regents Of The Leland Stanford Junior University | Therapeutic enzyme formulations and uses thereof in celiac sprue and/or dermatitis herpetoformis |
| US20060095096A1 (en) | 2004-09-09 | 2006-05-04 | Debenedictis Leonard C | Interchangeable tips for medical laser treatments and methods for using same |
| WO2006096527A2 (en) | 2005-03-04 | 2006-09-14 | Diversa Corporation | Nucleic acids and proteins and methods for making and using them |
| WO2007044906A2 (en) | 2005-10-11 | 2007-04-19 | Alvine Pharmaceuticals, Inc. | Compositions and methods for enhanced gastrointestinal stability of oligopeptides and polypeptides |
| CA2644273A1 (en) | 2006-04-05 | 2008-03-27 | Metanomics Gmbh | Process for the production of a fine chemical |
| US20080115411A1 (en) | 2006-11-16 | 2008-05-22 | Ramsey Philip W | Weed control system |
| US7645977B2 (en) | 2006-11-17 | 2010-01-12 | New Visual Media Group, L.L.C. | Low cost dynamic insulated glazing unit |
| CN101627098B (zh) | 2006-12-04 | 2013-04-24 | 三菱瓦斯化学株式会社 | 含有甲醛系聚合物的树脂材料的粘接方法以及结构体 |
| CA2680590C (en) | 2007-03-16 | 2017-10-17 | Jonathan David Gass | Combination enzyme therapy for digestion of dietary gluten |
| WO2008115428A2 (en) | 2007-03-16 | 2008-09-25 | The Board Of Trustees Of The Leland Stanford Junior University | A scaleable manufacturing process for cysteine endoprotease b, isoform 2 |
| EP2229404A4 (en) | 2007-12-10 | 2011-03-09 | Univ Leland Stanford Junior | ENZYMATIC POLYTHERAPY FOR GASTRIC DIGESTION OF FOOD GLUTEN IN PATIENTS WITH CELIAC DISEASE |
| EP2100900A1 (en) | 2008-03-07 | 2009-09-16 | Universitätsspital Basel | Bombesin analog peptide antagonist conjugates |
| WO2010021752A1 (en) | 2008-08-21 | 2010-02-25 | Alvine Pharmaceuticals, Inc. | Formulation for oral administration of proteins |
| JP2012505211A (ja) | 2008-10-10 | 2012-03-01 | アルヴィン ファーマシューティカルズ インコーポレーティッド | チモーゲンの迅速な活性化を促進する剤形 |
| CN101732504A (zh) * | 2010-01-06 | 2010-06-16 | 宋晓翠 | 猪笼草和艾蒿、香蒲草制成的妇科药物及其制备方法 |
| WO2011097266A1 (en) | 2010-02-02 | 2011-08-11 | Amano Enzyme Usa, Ltd. | Use of proteases for gluten intolerance |
| US20130045195A1 (en) | 2010-03-30 | 2013-02-21 | Alvine Pharmaceuticals, Inc. | Proteases for Degrading Gluten |
| WO2012006384A2 (en) * | 2010-07-07 | 2012-01-12 | Trustees Of Boston University | Rothia species gluten-degrading enzymes and uses thereof |
| US9023345B2 (en) | 2011-03-01 | 2015-05-05 | Novus International, Inc. | Methods for improving gut health |
| WO2012145369A1 (en) * | 2011-04-22 | 2012-10-26 | Faerstein Paul Joseph | Compositions and methods for nutritional supplementation |
| US9005610B2 (en) | 2012-11-21 | 2015-04-14 | Nepetx, Llc | Treatment of gluten intolerance and related conditions |
| US8837173B2 (en) | 2013-01-02 | 2014-09-16 | Chicony Power Technology Co., Ltd | DC to DC power converting device |
| EP2948170B1 (en) | 2013-01-23 | 2020-08-19 | Alvine Pharmaceuticals, Inc. | Pharmaceutical compositions for treating celiac disease and gluten intolerance |
| DK3220946T3 (da) | 2014-06-16 | 2021-08-02 | Codexis Inc | Sammensætninger og fremgangsmåder til dæmpning og forebyggelse af tarminflammation på grund af tilstedeværelsen af peptidiske fødevareantigener i tarmen |
| US10857214B2 (en) | 2015-12-16 | 2020-12-08 | Codexis, Inc. | Compositions and methods for treating gluten intolerance and disorders arising therefrom |
-
2015
- 2015-06-16 DK DK15809878.0T patent/DK3220946T3/da active
- 2015-06-16 CN CN202110951692.8A patent/CN113827708A/zh active Pending
- 2015-06-16 SI SI201531696T patent/SI3220946T1/sl unknown
- 2015-06-16 CN CN201580043762.2A patent/CN106794228B/zh active Active
- 2015-06-16 WO PCT/CA2015/000389 patent/WO2015192211A1/en active Application Filing
- 2015-06-16 EP EP21167330.6A patent/EP3943104A1/en active Pending
- 2015-06-16 ES ES15809878T patent/ES2883347T3/es active Active
- 2015-06-16 EP EP15809878.0A patent/EP3220946B1/en active Active
- 2015-06-16 JP JP2016573565A patent/JP6829077B2/ja active Active
- 2015-06-16 US US14/741,396 patent/US20160022785A1/en not_active Abandoned
-
2018
- 2018-02-27 US US15/906,972 patent/US10960059B2/en active Active
-
2021
- 2021-01-21 JP JP2021007953A patent/JP7369893B2/ja active Active
- 2021-02-22 US US17/181,924 patent/US11723960B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017519763A5 (ja) | ||
| JP6267190B2 (ja) | 悪液質の予防用または治療用組成物 | |
| JP2019533722A5 (ja) | ||
| JP2018511327A5 (ja) | ||
| JP2015517489A5 (ja) | ||
| BRPI1013877A2 (pt) | Sequências de aminoácidos melhoradas contra il-6r e polipeptídeos que compreendem os mesmos para o tratamento de doenças e distúrbios relacionados com il-6r | |
| JP2015510393A5 (ja) | ||
| MX2012008999A (es) | Composicion farmaceutica para el tratamiento y/o prevencion del cancer. | |
| MX340015B (es) | Composicion farmaceutica para el tratamiento y/o prevencion del cancer. | |
| MX2012009000A (es) | Composicion farmaceutica para el tratamiento y/o prevencion del cancer. | |
| JP2014530010A5 (ja) | ||
| JP2015517488A5 (ja) | ||
| TWI797116B (zh) | 用於治療上皮細胞屏障功能病症的蛋白質 | |
| Edwards et al. | Perinatal hypoxic-ischemic encephalopathy and neuroprotective peptide therapies: A case for cationic arginine-rich peptides (CARPs) | |
| JP6158712B2 (ja) | 新規合成ペプチド及びそれらの使用 | |
| JP2011528897A5 (ja) | ||
| YF Chen et al. | Potential clinical applications of multi-functional milk proteins and peptides in cancer management | |
| WO2017137920A3 (en) | Use of bacterial strains belonging to the species lactobacillus kefiri in paediatrics to generate and/or maintain a state of homeostasis | |
| MX2014004953A (es) | Ligadores basados en tirosina para la conexion desprendible de peptidos. | |
| Lisitsyn et al. | Enteric alpha defensins in norm and pathology | |
| WO2013014134A3 (en) | Polyoma virus jc peptides and proteins in vaccination and diagnostic applications | |
| RU2016107873A (ru) | Пептиды | |
| JP2008531463A5 (ja) | ||
| NZ601980A (en) | Recombinant proteins for use in vaccine, antibodies against said proteins, and diagnostic and therapeutic methods including the same | |
| RU2019113989A (ru) | Лекарственное средство |